Jodi Akin

Jodi Akin is the Founding CEO and a member of the Board of Directors at Hawthorne Effect, Inc., a company established in 2015 that enhances patient engagement in clinical trials through the integration of technology and professionalism. In addition to leadership at Hawthorne Effect, Jodi Akin serves as an Angel Investor and advisory member at Astia, focusing on promoting inclusive leadership in high-potential companies. Moreover, Jodi Akin holds board positions at 510 Kardiac Devices, Inc. and has been the Chief Scientific Advisor at PiCardia, Inc. Prior experience includes serving as Vice President of Global Clinical Affairs at Edwards Lifesciences, CEO roles at Novovascular, Inc., preEminent, LLC, and co-founding Vasconnect, Inc. Jodi Akin's academic credentials include a BSFS in Diplomacy, Economics, and International Affairs from Georgetown University, an MSN in Nursing from Pace University, and an Advanced Critical Care degree from the University of California, San Francisco.